An Open-label, Single Dose, Randomized, Two-period Crossover Study to Investigate the Bioavailability of a Novel Dosage Form of Dutasteride in Healthy Male Subjects
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Acronyms ARI115148
- Sponsors GSK
- 23 Apr 2012 New trial record